StonvexLoading…
StonvexStonvexStonvexCore line items from IBP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.97B | $2.94B | $2.78B | $2.67B |
Operating Income | $386.40M | $382.50M | $369.10M | $345.40M |
Net Income | $265.40M | $256.60M | $243.70M | $223.40M |
EPS (Diluted) | $9.71 | $9.10 | $8.61 | $7.74 |
Total Assets | $2.07B | $2.06B | $1.98B | $1.78B |
Total Liabilities | $1.36B | $1.35B | $1.31B | $1.29B |
Cash & Equivalents | $321.90M | $327.60M | $386.50M | $229.60M |
Free Cash Flow OCF − CapEx | $300.80M | $251.40M | $278.60M | $232.30M |
Shares Outstanding | 26.98M | 27.76M | 28.37M | 28.31M |